88 Avsnitt

  1. Acute hepatitis C

    Publicerades: 2019-03-08
  2. Epidemiology of chronic liver disease

    Publicerades: 2019-02-08
  3. Viral hepatitis in migrant populations

    Publicerades: 2018-12-07
  4. DAA treatment for hepatitis C among people who inject drugs

    Publicerades: 2018-10-25
  5. Pancreatic cancer treatment

    Publicerades: 2018-09-06
  6. UDCA Response Score

    Publicerades: 2018-08-10
  7. Global prevalence, treatment, and prevention of hepatitis B virus infection

    Publicerades: 2018-05-03
  8. Neoplasia detection in ulcerative colitis

    Publicerades: 2018-04-06
  9. Functional dyspepsia

    Publicerades: 2018-03-08
  10. Can DAA therapy for HCV reactivate HBV in coinfected patients?

    Publicerades: 2018-02-08
  11. Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018

    Publicerades: 2018-01-13
  12. Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018

    Publicerades: 2017-12-09
  13. PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017

    Publicerades: 2017-11-09
  14. Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017

    Publicerades: 2017-09-02
  15. Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017

    Publicerades: 2017-08-19
  16. Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017

    Publicerades: 2017-08-03
  17. HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017

    Publicerades: 2017-07-06
  18. Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017

    Publicerades: 2017-06-08
  19. Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017

    Publicerades: 2017-05-05
  20. Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017

    Publicerades: 2017-04-06

4 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Visit the podcast's native language site